Fulltext

Effects of angiotensin converting enzyme inhibition on endothelial vasodilator function in primary human hypertension

Kiowski, W. ; Linder, L. ; Nuesch, R. ; Martina, B.

In: European Heart Journal, 1993, vol. 14, p. 5-9

Ajouter à la liste personnelle
    Titre
    • Effects of angiotensin converting enzyme inhibition on endothelial vasodilator function in primary human hypertension
    Auteur
    • Kiowski, W.. Division of Cardiology, Department of Internal Medicine, University Hospital Zurich, Switzerland
    • Linder, L.. Division of Cardiology, Department of Medicine, University Hospital Basel, Switzerland
    • Nuesch, R.. Division of Medical Policlinic, Department of Medicine, University Hospital Basel, Switzerland
    • Martina, B.. Division of Medical Policlinic, Department of Medicine, University Hospital Basel, Switzerland
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:291673
    Summary
    Hypertension in animal models and in humans is associated with a decreased vasodilator response to acetylcholine which causes vascular relaxation by release of endothelium-derived relaxing factor from the endothelium. Since lowering of blood pressure, particularly with angiotensin converting enzyme inhibitors, improved the response to acetylcholine we investigated the effects of brachial artery infusions of ascending dosages of actetylcholine on forearm blood flow before and after 5 months of therapy with the angiotensin converting enzyme inhibitor, cilazapril, in 10 patients with mild to moderate primary hypertension. Cilazapril decreased blood pressure from 150.8 ± 14.4/98.9 ± 4.3 mmHg during placebo to 138.8 ± 15.6/88.6 ± 8.9 mmHg (P < 0.01). Brachial artery acetylcholine infusions increased forearm blood flow from 2.95 ± 1.5 to a maximum of 22.8 ± 11.5 ml.min−1.100 ml−1 forearm tissue and decreased forearm vascular resistance from 48.1 ± 34.1 to 6.9 ± 6.9 units before cilazapril. This response did not change after cilazapril therapy. Our findings in patients with primary hypertension, therefore, do not support the concept that angiotensin converting enzyme inhibition influences endothelium-dependent vascular relaxation to acetylcholine to a significant degree. Whether this lack of effect on endothelial vasodilator function is specific for the vascular bed chosen for study or whether it represents a fundamental difference between animal models and human hypertension remains an important issue to be clarified